Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
NPJ Digital Medicine|November 10, 2025
Automated detection of radiolucent foreign body aspiration on chest CT using deep learningXiaofan Liu, Zhe Chen, Zhiyong Tang, et al.
Signal Transduction and Targeted Therapy|April 23, 2024
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trialYunfei Chen, Yanmei Xu, Ying Chi, et al.
Platelets|January 3, 2023
Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics studyXiaofan Liu, Yusheng Bai, Tao Wang, et al.
Cell|March 20, 2026
Hijacking ERAD for targeted degradation of transmembrane proteinsHaikun Song, Wei Wang, Tingfang Mei, et al.
BMJ (Clinical Research Ed.)|October 21, 2025
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trialYunfei Chen, Yanmei Xu, Jiawen Dai, et al.
The Lancet. Haematology|April 7, 2023
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 studyXiaofan Liu, Hu Zhou, Yu Hu, et al.
The Lancet. Haematology|May 22, 2022
Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trialFeng Xue, Huiyuan Li, Xia Wu, et al.
Blood|January 15, 2026
Single-Cell Profiling of ANKRD26 Thrombocytopenia Reveals Progenitor Expansion and Polyploid Apoptosis via JUNB-p21Lin Chen, Lanyue Hu, Xiaofan Liu, et al.
Annals of Hematology|June 6, 2024
Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trialHeng Mei, Xiaofan Liu, Yan Li, et al.
Research and Practice in Thrombosis and Haemostasis|December 10, 2025
Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trialHeng Mei, Xiaofan Liu, Yan Li, et al.
Pageof 17